Future Directions in Evaluating Nocturia and Its Impact in Patients with LUTS/BPH
Andrea Tubaro(Sapienza University of Rome), Herman Stoevelaar(Barnes-Jewish Hospital), Emmanuel Chartier‐Kastler(Sorbonne Université), Philip Van Kerrebroeck(Maastricht University Medical Centre), Christopher R. Chapple(Sheffield Teaching Hospitals NHS Foundation Trust), José E. Batista(Fundación Teknon), R. Berges(Ruhr University Bochum)
Cited by 4
Related Papers
European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era
|European Urology|2020|313
Randomised, placebo-controlled, double-blind clinical trial of β-sitosterol in patients with benign prostatic hyperplasia
|The Lancet|1995|290
Urology practice during the COVID-19 pandemic
|Minerva Urologica e Nefrologica|2020|256
Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful During and After the COVID-19 Pandemic?
|European Urology|2020|207
International Continence Society best practice statement for use of sacral neuromodulation
|Neurourology and Urodynamics|2018|173